PT  - JOURNAL ARTICLE
AU  - Hoogwerf, Byron J.
TI  - Exenatide and pramlintide: New glucose-lowering agents for treating diabetes mellitus
DP  - 2006 May 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 477--484
VI  - 73
IP  - 5
4099  - http://www.ccjm.org/content/73/5/477.short
4100  - http://www.ccjm.org/content/73/5/477.full
SO  - Cleve Clin J Med2006 May 01; 73
AB  - Insulin is not the only hormone that regulates plasma glucose levels. Glucagon-like peptide 1 (GLP-1), produced in the small intestine, and amylin, produced by beta cells in the pancreas, also have glucose-lowering effects. Synthetic analogues of these hormones are now available for clinical use.